ahlam1399
08-31-2015, 02:05 PM
UPDATE 1-Bayer heart failure drug cuts deaths in mid-stage trial
* May launch in 2020/21, analysts see potential $2 bln sales (Updates with comment from lead investigator)
http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/a2.img (http://da.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/ach.img (http://adchoice.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/ach.htm)http://pi.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/a2t.imghttp://pi2.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/496f1213/sc/28/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=sqelY2plFxs:bSNR5xJKKvY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=sqelY2plFxs:bSNR5xJKKvY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=sqelY2plFxs:bSNR5xJKKvY:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=sqelY2plFxs:bSNR5xJKKvY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=sqelY2plFxs:bSNR5xJKKvY:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/sqelY2plFxs
* May launch in 2020/21, analysts see potential $2 bln sales (Updates with comment from lead investigator)
http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/a2.img (http://da.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/ach.img (http://adchoice.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/ach.htm)http://pi.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/a2t.imghttp://pi2.feedsportal.com/r/238384991777/u/49/f/654213/c/35217/s/496f1213/sc/28/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/496f1213/sc/28/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=sqelY2plFxs:bSNR5xJKKvY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=sqelY2plFxs:bSNR5xJKKvY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=sqelY2plFxs:bSNR5xJKKvY:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=sqelY2plFxs:bSNR5xJKKvY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=sqelY2plFxs:bSNR5xJKKvY:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/sqelY2plFxs